Temporal trends in stillbirth over eight decades in England and Wales: A longitudinal analysis of over 56 million births and lives saved by improvements in maternity care.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
17 Sep 2022
Historique:
entrez: 16 9 2022
pubmed: 17 9 2022
medline: 21 9 2022
Statut: epublish

Résumé

Considering the public health importance of stillbirth, this study quantified the trends in stillbirths over eight decades in England and Wales. This longitudinal study utilized the publicly available aggregated data from the Office for National Statistics that captured maternity information for babies delivered in England and Wales from 1940 to 2019. We computed the trends in stillbirth with the associated incidence risk difference, incidence risk ratio, and extra lives saved per decade. From 1940-2019, 56 906 273 births were reported. The stillbirth rate declined (85%) drastically up to the early 1980s. In the initial five decades, the estimated number of deaths per decade further decreased by 67 765 (9.49/1000 births) in 1940-1949, 2569 (0.08/1000 births) in 1950-1959, 9121 (3.50/1000 births) in 1960-1969, 15 262 (2.31/1000 births) in 1970-1979, and 10 284 (1.57/1000 births) in 1980-1989. However, the stillbirth rate increased by an additional 3850 (0.58/1000 births) stillbirths in 1990-1999 and 693 (0.11/1000 births) stillbirths in 2000-2009. The stillbirth rate declined again during 2010-2019, with 3714 fewer stillbirths (0.54/1000 births). The incidence of maternal age <20 years reduced over time, but pregnancy among older women (>35 years) increased. The stillbirth rate declined drastically, but the rate of decline slowed in the last three decades. Though teenage pregnancy (<20 years) had reduced, the prevalence of women with a higher risk of stillbirth may have risen due to an increase in advanced maternal age. Improved, more personalised care is required to reduce the stillbirth rate further.

Sections du résumé

Background UNASSIGNED
Considering the public health importance of stillbirth, this study quantified the trends in stillbirths over eight decades in England and Wales.
Methods UNASSIGNED
This longitudinal study utilized the publicly available aggregated data from the Office for National Statistics that captured maternity information for babies delivered in England and Wales from 1940 to 2019. We computed the trends in stillbirth with the associated incidence risk difference, incidence risk ratio, and extra lives saved per decade.
Results UNASSIGNED
From 1940-2019, 56 906 273 births were reported. The stillbirth rate declined (85%) drastically up to the early 1980s. In the initial five decades, the estimated number of deaths per decade further decreased by 67 765 (9.49/1000 births) in 1940-1949, 2569 (0.08/1000 births) in 1950-1959, 9121 (3.50/1000 births) in 1960-1969, 15 262 (2.31/1000 births) in 1970-1979, and 10 284 (1.57/1000 births) in 1980-1989. However, the stillbirth rate increased by an additional 3850 (0.58/1000 births) stillbirths in 1990-1999 and 693 (0.11/1000 births) stillbirths in 2000-2009. The stillbirth rate declined again during 2010-2019, with 3714 fewer stillbirths (0.54/1000 births). The incidence of maternal age <20 years reduced over time, but pregnancy among older women (>35 years) increased.
Conclusions UNASSIGNED
The stillbirth rate declined drastically, but the rate of decline slowed in the last three decades. Though teenage pregnancy (<20 years) had reduced, the prevalence of women with a higher risk of stillbirth may have risen due to an increase in advanced maternal age. Improved, more personalised care is required to reduce the stillbirth rate further.

Identifiants

pubmed: 36112509
doi: 10.7189/jogh.12.04072
pmc: PMC9480862
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

04072

Informations de copyright

Copyright © 2022 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and declare no relevant interests.

Références

Eur J Obstet Gynecol Reprod Biol. 2021 Jan;256:235-245
pubmed: 33248379
Prenat Diagn. 2002 Nov;22(11):966-72
pubmed: 12424757
Am J Obstet Gynecol. 2005 Dec;193(6):1923-35
pubmed: 16325593
Aust N Z J Public Health. 2014 Aug;38(4):384-9
pubmed: 24750492
CMAJ. 2013 May 14;185(8):E345-51
pubmed: 23569166
Eur J Obstet Gynecol Reprod Biol. 2007 Jan;130(1):60-5
pubmed: 16460869
Lancet. 2011 May 14;377(9778):1703-17
pubmed: 21496907
BMC Pregnancy Childbirth. 2009 Nov 27;9:55
pubmed: 19943928
Am J Obstet Gynecol. 2015 May;212(5):673.e1-11
pubmed: 25530599
Lancet. 2016 Feb 6;387(10018):587-603
pubmed: 26794078
NCHS Data Brief. 2009 Apr;(16):1-8
pubmed: 19389328
Int J Epidemiol. 2000 Jun;29(3):542-8
pubmed: 10869329
Ultrasound Obstet Gynecol. 2022 Jan;59(1):55-60
pubmed: 34319638
BJOG. 2012 Feb;119(3):306-14
pubmed: 22168794
J Matern Fetal Neonatal Med. 2004 Aug;16(2):79-94
pubmed: 15512717
Bull World Health Organ. 2008 Jun;86(6):460-6
pubmed: 18568275
BJOG. 2021 Jan;128(2):149-156
pubmed: 32613730
BMC Pregnancy Childbirth. 2018 Apr 20;18(1):109
pubmed: 29678157
JAMA. 2002 Mar 27;287(12):1561-7
pubmed: 11911759
BMC Med. 2014 Nov 27;12:220
pubmed: 25428603
Lancet. 2016 Feb 13;387(10019):691-702
pubmed: 26794070
Aust N Z J Public Health. 2002 Apr;26(2):125-31
pubmed: 12054330
BJOG. 2012 Dec;119(13):1630-9
pubmed: 23164112

Auteurs

Gbenga A Kayode (GA)

Translational Health Science, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, United Kingdom.

Andrew Judge (A)

Translational Health Science, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, United Kingdom.

Christy Burden (C)

Translational Health Science, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, United Kingdom.

Cathy Winter (C)

Royal College of Midwives, London, United Kingdom.
The PROMPT Maternity Foundation, Department of Women's Health, Southmead Hospital, Bristol, United Kingdom.

Tim Draycott (T)

Translational Health Science, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, United Kingdom.
The PROMPT Maternity Foundation, Department of Women's Health, Southmead Hospital, Bristol, United Kingdom.
Royal College of Obstetricians and Gynaecologists, London, United Kingdom.

Basky Thilaganathan (B)

Royal College of Obstetricians and Gynaecologists, London, United Kingdom.
St. George's University Hospitals, London, United Kingdom.

Erik Lenguerrand (E)

Translational Health Science, Bristol Medical School, University of Bristol, Southmead Hospital, Bristol, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH